Oncology

252 Items

All Items

$Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study$

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin

1089–1095
Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

161-169
Prevalence, clinical features and prognosis of malignant solid tumors in infants: a 14-year study

Tian Zhi, Wei-Ling Zhang, Yi Zhang, Yi-Zhuo Wang, Dong-Sheng Huang

598-606
Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study

Sibel Cetintas, Gulcin Tezcan, Berrin Tunca, Unal Egeli, Mustafa Sehsuvar Gokgoz, Gulsah Cecener

172-179
Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index

Nulifer Kilic Durankus, Efsun Somay, Sibel Bascil, Sukran Senyurek, Duriye Ozturk, Ugur Selek, Erkan Topkan

240–248
Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas

Aura Jurescu, Alis Dema, Adrian Văduva, Adelina Gheju, Octavia Vița, Robert Barna, Codruța Lăzureanu, Marioara Cornianu, Sorina Tăban, Ciprian Duță, Stelian Pantea

164-177
Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey

İlhami Gok, Meryem Baday, Suleyman Cetinkunar, Kemal Kilic, Bulent Caglar Bilgin

214-218
PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway

Linhai Huang, Chundi Liao, Hanhua Wu, Piwei Huang

992-1004
Plasma exosome-derived fragile site-associated tumor suppressor as a powerful prognostic predictor for patients with ovarian cancer

Renjing Hu, Xiaochun Chen, Shiliang Zhang, Bin Liu, Hao Pei, Fan Tu, Jun Liu, Hao Yu

453-459
PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos

Huiming Nong, Xiru Zhang, Yingxue Yuan, Junhong Zhang, Jingyi Zhao, Zhixin Cao

2537–2550
Perforation of gastric cancer - What should the surgeon do?

Nebojsa Ignjatovic, Dragan Stojanov, Miodrag Djordjevic, Jelena Ignjatovic, Daniela Benedeto Stojanov, Bobana Milojkovic

222-226
PCAT1 is a poor prognostic factor in endometrial carcinoma and associated with cancer cell proliferation, migration and invasion

Xiaohuan Zhao, Yali Fan, Changqiong Lu, Hongfang Li, Ning Zhou, Gaogao Sun, Hong Fan

274-281
Pattern of Head and Neck Malignant Tumours in a Tuzla ENT Clinic – A Five Year Experience

Hasan Altumbabić, Almir Salkić, Almedina Ramaš, Musfaha Burgić, Merima Kasumović, Fuad Brkić

377-380
P2X7 receptor as an independent prognostic indicator in gastric cancer

Ilknur Calik, Muhammet Calik, Burcu Sarikaya, Ibrahim Hanifi Ozercan, Ramazan Arslan, Gokhan Artas, Adile Ferda Dagli

188-196
Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway

Jianjun Han, Jingjing Yu, Yu'na Dai, Jumei Li, Meiyan Guo, Jingzhen Song, Xuefeng Zhou

52-59
Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1

Xu Guo, Haozhe Piao, Ye Zhang, Peixin Sun, Bing Yao

459-470
Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy

Xin-xin Du, Rong Yu, Zhen-fei Wang, De-cheng Du, Qiao-yun Liu, Run-mei Wang, Shi-rong Kang, Hao Yang

186-194
Our Experiences with Erlotinib in Second and Third Line Treatment Patients with Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer

Bakir Mehić, Mirko Stanetić, Ljuljeta Tinjić, Vlatka Smoljanović

386-390
Orbital metastases from breast cancer: a case report

Mirjana Janicijevic-Petrovic, Tatjana Sarenac, Suncica Sreckovic, Dejan Vulovic, Katarina Janicijevic

253-255
OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma

Jingrong Deng, Changfa Shu, Dong Wang, Richard Nimbona, Xingping Zhao, Dabao Xu

2308–2323

Previous 81-100 of 252 Next

Oncology

All Items

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Prevalence, clinical features and prognosis of malignant solid tumors in infants: a 14-year study

Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study

Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index

Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas

Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey

PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway

Plasma exosome-derived fragile site-associated tumor suppressor as a powerful prognostic predictor for patients with ovarian cancer

PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos

Perforation of gastric cancer - What should the surgeon do?

PCAT1 is a poor prognostic factor in endometrial carcinoma and associated with cancer cell proliferation, migration and invasion

Pattern of Head and Neck Malignant Tumours in a Tuzla ENT Clinic – A Five Year Experience

P2X7 receptor as an independent prognostic indicator in gastric cancer

Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway

Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1

Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy

Our Experiences with Erlotinib in Second and Third Line Treatment Patients with Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer

Orbital metastases from breast cancer: a case report

OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma

impact_factor_6

Sidebar_menu